Increasing the throughput of label-free cell assays to study the activation of G-protein-coupled receptors by using a serial agonist exposure protocol.
ECIS
G-protein-coupled receptor
electric cell–substrate impedance sensing
impedance-based cellular assay
label-free
wholistic cell assay
Journal
Integrative biology : quantitative biosciences from nano to macro
ISSN: 1757-9708
Titre abrégé: Integr Biol (Camb)
Pays: England
ID NLM: 101478378
Informations de publication
Date de publication:
01 Mar 2019
01 Mar 2019
Historique:
received:
23
01
2019
revised:
12
03
2019
accepted:
03
05
2019
medline:
15
5
2019
pubmed:
15
5
2019
entrez:
15
5
2019
Statut:
ppublish
Résumé
Label-free, holistic assays, monitoring, for example, the impedance of cells on electrodes, are gaining increasing popularity in the evaluation of G-protein-coupled receptor (GPCR) ligands. It is the strength of these approaches to provide the integrated cellular response non-invasively, highly automated and with a device-dependent time resolution down to several milliseconds. With an increasing number of samples to be studied in parallel, the available time resolution is, however, reduced and the cost for the disposable sensor arrays may become limiting. Inspired by protocols from organ pharmacology, we investigated a simple serial agonist addition assay that circumvents these limitations in impedance-based cellular assays. Using a serial addition of increasing concentrations of a GPCR agonist while continuously monitoring the sample's impedance, we were able to establish a full concentration-response curve for the endogenous agonist histamine on a single layer of U-373 MG cells endogenously expressing the histamine 1 receptor (H1R). This approach is validated with respect to conventional, parallel agonist addition protocols and studies using H1R antagonists such as mepyramine. Applicability of the serial agonist addition assay was shown for other GPCRs known for their signaling via one of the canonical G-protein pathways, Gq, Gi/0 or Gs as well. The serial agonist addition protocol has the potential to further strengthen the output of label-free analysis of GPCR activation.
Identifiants
pubmed: 31083709
pii: 5488806
doi: 10.1093/intbio/zyz010
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
99-108Informations de copyright
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.